Quest Diagnostics Other Income (Expense) decreased by 16.1% to -$65.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from -$70.00M to -$65.00M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows a downward trend with a 7.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $284.00M | $2.00M | -$61.00M | -$65.00M | -$41.00M | -$26.00M | -$28.00M | -$31.00M | -$43.00M | -$30.00M | -$34.00M | -$41.00M | -$34.00M | -$62.00M | -$70.00M | -$54.00M | -$58.00M | -$56.00M | -$65.00M |
| QoQ Change | — | -99.3% | <-999% | -6.6% | +36.9% | +36.6% | -7.7% | -10.7% | -38.7% | +30.2% | -13.3% | -20.6% | +17.1% | -82.4% | -12.9% | +22.9% | -7.4% | +3.4% | -16.1% |
| YoY Change | — | — | — | -122.9% | <-999% | — | +54.1% | +52.3% | -4.9% | -15.4% | -21.4% | -32.3% | +20.9% | -106.7% | -105.9% | -31.7% | -70.6% | +9.7% | +7.1% |